Its overexpression can inhibit metastasis and invasion of GBM cells by directly repressing FAK, a mediator of cell‐extracellular matrix signaling, as well as by reducing the expression of MMP2 and MMP9, thereby decreasing the ability of GBM cells to move through extracellular matrix 75. The gene discussed is MMP9; the disease is glioblastoma.